hydroxychloroquine has been researched along with pci 32765 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, T; Delgado, J; Montserrat, E | 1 |
| Du, Y; Gao, H; Lei, L; Li, Y; Tong, F; Wang, X; Xia, X; Yang, Z | 1 |
2 other study(ies) available for hydroxychloroquine and pci 32765
| Article | Year |
|---|---|
CLL and COVID-19 at the Hospital Clinic of Barcelona: an interim report.
Topics: Adenine; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents; Antiviral Agents; Betacoronavirus; Biomarkers; Coronavirus Infections; COVID-19; Disease Progression; Female; Ferritins; Fibrin Fibrinogen Degradation Products; Humans; Hydroxychloroquine; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphopenia; Male; Middle Aged; Pandemics; Piperidines; Pneumonia, Viral; Prevalence; Protein Kinase Inhibitors; Pyrazoles; Pyrimidines; SARS-CoV-2; Spain; Survival Analysis | 2020 |
Co-delivery of ibrutinib and hydroxychloroquine by albumin nanoparticles for enhanced chemotherapy of glioma.
Topics: Animals; Cell Line, Tumor; Glioma; Humans; Hydroxychloroquine; Mice; Nanoparticles; Serum Albumin, Human; Tissue Distribution | 2023 |